Clearstead Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.08M Sell
7,931
-473
-6% -$184K 0.04% 252
2025
Q1
$3.66M Sell
8,404
-371
-4% -$161K 0.06% 214
2024
Q4
$3.24M Buy
8,775
+12
+0.1% +$4.43K 0.05% 230
2024
Q3
$4.56M Sell
8,763
-95
-1% -$49.4K 0.07% 197
2024
Q2
$4.8M Buy
8,858
+7,167
+424% +$3.88M 0.08% 180
2024
Q1
$911K Buy
1,691
+4
+0.2% +$2.16K 0.05% 239
2023
Q4
$796K Sell
1,687
-3,345
-66% -$1.58M 0.04% 251
2023
Q3
$2.19M Buy
5,032
+2,538
+102% +$1.11M 0.06% 200
2023
Q2
$1.11M Buy
2,494
+61
+3% +$27.1K 0.07% 194
2023
Q1
$1.12M Buy
2,433
+60
+3% +$27.6K 0.08% 172
2022
Q4
$1.22M Buy
2,373
+2
+0.1% +$1.03K 0.1% 161
2022
Q3
$1.08M Buy
2,371
+52
+2% +$23.6K 0.1% 151
2022
Q2
$1.12M Buy
2,319
+90
+4% +$43.5K 0.09% 163
2022
Q1
$1.1M Buy
2,229
+2
+0.1% +$983 0.07% 172
2021
Q4
$1.03M Buy
2,227
+56
+3% +$26K 0.07% 178
2021
Q3
$809K Buy
2,171
+132
+6% +$49.2K 0.06% 192
2021
Q2
$778K Buy
2,039
+18
+0.9% +$6.87K 0.06% 189
2021
Q1
$726K Buy
2,021
+191
+10% +$68.6K 0.06% 186
2020
Q4
$588K Buy
1,830
+152
+9% +$48.8K 0.05% 192
2020
Q3
$451K Sell
1,678
-2
-0.1% -$538 0.05% 186
2020
Q2
$442K Sell
1,680
-18
-1% -$4.74K 0.05% 190
2020
Q1
$386K Buy
1,698
+29
+2% +$6.59K 0.06% 173
2019
Q4
$504K Sell
1,669
-4
-0.2% -$1.21K 0.06% 177
2019
Q3
$402K Buy
1,673
+43
+3% +$10.3K 0.05% 187
2019
Q2
$460K Buy
1,630
+2
+0.1% +$564 0.06% 178
2019
Q1
$467K Buy
1,628
+262
+19% +$75.2K 0.06% 174
2018
Q4
$359K Buy
1,366
+49
+4% +$12.9K 0.06% 189
2018
Q3
$361K Buy
1,317
+2
+0.2% +$548 0.05% 181
2018
Q2
$313K Buy
1,315
+2
+0.2% +$476 0.04% 188
2018
Q1
$288K Buy
1,313
+2
+0.2% +$439 0.04% 190
2017
Q4
$295K Sell
1,311
-118
-8% -$26.6K 0.04% 180
2017
Q3
$271K Sell
1,429
-15
-1% -$2.85K 0.04% 207
2017
Q2
$272K Buy
1,444
+21
+1% +$3.96K 0.04% 198
2017
Q1
$235K Buy
+1,423
New +$235K 0.03% 200